Pharmacological activities of chromene derivatives: An overview

Asian Journal of Pharmaceutical and Clinical Research

Volumn 6, Issue SUPPL. 2, 2013, Pages 11-15

  Thomas, Nancy ^a   Zachariah, Subin Mary ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

2H chromene; 4H chromene; Anticancer activity and anti inflammatory activity

Indexed keywords

1 [(4 CHLORO 2,2 DIMETHYL 2H CHROMEN 3 YL)METHYLENE]THIOSEMICABAZIDE; 2 AMINO 4 (3 BROMO 4,5 DIMETHOXYPHENYL) 7 (DIMETHYLAMINO) 4H CHROMENE 3 CARBONITRILE; 2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; 2 AMINO 7 (DIMETHYLAMINO) 4 (7 METHOXY 1,3 BENZODIOXOL 5 YL) 4H CHROMENE 3 CARBONITRILE; 5,7 DIMETHOXY 2 METHYL 2H CHROMENE; 5,7 DIMETHOXY 2,8 DIMETHYL 2H CHROMENE; 6 (4 HYDROXYBENZOYL) 2 (TRIFLUOROMETHYL) 2H CHROMENE 3 CARBOXYLIC ACID; 6 CHLORO 2 (TRIFLUOROMETHYL) 4 PHENYL 2H CHROMENE 3 CARBOXYLIC ACID; 6 CHLORO 7 (4 NITROPHENOXY) 2 (TRIFLUOROMETHYL) 2H CHROMENE 3 CARBOXYLIC ACID; 6 CHLORO 8 METHYL 2 (TRIFLUOROMETHYL) 2H CHROMENE 3 CARBOXYLIC ACID; 6,7 DIMETHYL 3 [[METHYL [2 [METHYL [1 (3 TRIFLUOROMETHYLPHEYL) 1H INDOL 3 YLMETHYL]AMINO]ETHYL]AMINO]METHYL]CHROMEN 4 ONE; 7 HYDROXY 6 METHOXY 4H CHROMENE; 7 METHOXY 2 (3,4,5 TRIMETHOXYPHENYL) 2H CHROMENE; ACRONINE; ALPHA TOCOPHEROL; CALANONE; CANNABICHROMENE; CHROMENE DERIVATIVE; COMBRETASTATIN A4; CONRAUINONE A; CROMAKALIM; DIHYDROPYRANO[3,2 C]CHROMENE DERIVATIVE; ERYSENEGALENSEIN C; INDOMETACIN; N [2 [(6 FLUORO 2H CHROMEN 8 YL)OXY]ETHYL] 4 (4 METHOXYPHENYL)BUTAN 1 AMINE; PHENYLBUTAZONE; SESELIN; TEPHROSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVAFZLELIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER RESISTANCE; DEGENERATIVE DISEASE; DOWN SYNDROME; DRUG BINDING SITE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; FEMALE INFERTILITY; GONORRHEA; HIV ASSOCIATED DEMENTIA; HUMAN; HUNTINGTON CHOREA; MYOCLONUS; NONHUMAN; PARKINSON DISEASE; PHARMACOPHORE; REVIEW; SCHIZOPHRENIA; STOMACH PAIN; STRUCTURE ACTIVITY RELATION;

EID: 84879153625     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Qiao Ren, Woon-Yew Siau, Zhiyun Du, Kun Zhang, Jian Wang. Expeditious assembly of a 2-Amino-4H-chromene skeleton by using an enantioselective mannich intramolecular ring cyclization-tautomerization cascade sequence. Chem Eur J 2011; 17:7781-7785.
2. Henriette G, Lorraine L, Bettina H, Clemence D, Kelly Dong, Irenej K, et al. Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. Mol Cancer Ther 2004; 3(11):1375-84.
3. Chetan BS, Nimesh MS, Manish PP, Ranjan GP. Microwave assisted synthesis of novel 4H-chromene derivatives bearing phenoxypyrazole and their antimicrobial activity assess. J Serb Chem Soc 2012; 77:1-17.
4. Milan M, Mirjana M, Desanka B, Sanja M, Neda N, Vladimir M, et al. In vitro antioxidant of selected 4-Hydroxy-chromene-2-one derivatives-SAR, QSAR and DFT studies. Int J Mol Sci 2011;12(5):2822-41.
5. Jie-Fei Cheng, Akira Ishikawa, Yoshinori Ono, Thomas Arrhenius, Alex Nadzan. Novel Chromene Derivatives as TNF-α Inhibitors. Bioorg Med Chem Lett 2003; 13: 3647-3650.
6. Suresh T, Arunima V, Atin K, Sandeep G, Prarthana VR, Ganesh RK. Novel chromeneimidazole derivatives as antifungal compounds: synthesis and in vitro evaluation. Acta Pol. Pharm 2010; 67:423-427.
7. Nareshkumar Jain, Jiayi Xu, Ramesh MK, Fuyong Du, Guo Jian-Zhong, Emmanuel Pacia, et al. Identification and Structure-Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms. J Med Chem 2009; 52 (23):7544-7569.
8. Mori J, Iwashima M, Takeuchi M, Saito H. A synthetic study on antiviral and antioxidative chromene derivative. Chem Pharm Bull 2006; 54(3):391-6.
9. Aliaa MK, Manal MK, Eman k Abd El-all and Heba AH Elshemy. Design and synthesis of substituted chromenes as potential anticancer agents. IJPRD 2012; 4(3):310-322.
10. Denish CK, Hetal KP, Nilesh KG. Synthesis, characterization & anti-HIV activity of 4-Hydroxy-3-(5-methylisoxazol-3-yl)pyrano(3,2-C)chromene-2,5-dione. AJBPR 2012; 2(2):126-130.
11. Nimesh RK, Dhaval DH, Prashant TM, Saurabh KP. Synthesis and evaluation of in vitro antitubercular activity and antimicrobial activity of some novel 4H-chromeno[2,3-d]pyrimidine via 2-amino-4-phenyl-4H-chromene-3-carbonitriles. Med Chem Res 2011; 20(7);854-864.
12. Nitin K, Sushil K, Himanshu G, Sharma PK. 3-Hydroxy-2-(substituted phenyl)-4H-chromen-4-one derivatives-synthesis, spectral characterization and pharmacological screening. WRJB 2012; 1(1): 1-5.
13. Bhat MA, Siddiqui N, Khan SA. Synthesis of novel 3-(4-acetyl-5H/methyl-5-substituted phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as potential anticonvulsant agents. Acta Pol Pharm 2008; 65(2):235-39.
14. Nicolaou KC, Pfefferkorn JA, Roecker AJ, Cao GQ, Barluenga S, Mitchell HJ. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans. J Am Chem Soc 2000; 122: 9939-9953.
15. Khairy AM, Mohsen MA, Yahia AM, Basyouni WM, Samir YA. Novel 4(3H)-quinazolinone containing biologically active thiazole, pyrazole, 1,3-dithiazole, pyridine, chromene, pyrazolopyrimidine and pyranochromene of expected biological activity. WJC 2009; 4 (2): 161-170.
16. Willem AL, Lindani NE, Samuel K, Garreth LM, Simon SM, Charles BK. Ring-closing metathesis for the synthesis of 2Hand 4H-chromenes. Tetrahedron 2005; 61: 9996-10006.
17. Hester L. V, Wei Z, Tore H, Floris PJT, Karl AJ. Formation of optically active chromanes by catalytic asymmetric tandem oxa-Michael addition-Friedel-Crafts alkylation reactions. Org Biomol Chem 2003; 1:1953-1958.
18. Charles DH, Babajide OO, Donna VE, David M, Jon C. Vafzelin, uvafzelin, novel constituents of Uvaria afzelii. J Am Chem Soc 1980; 102 (24):7365-7367.
19. Victorine F, Augustin EN, Z. Tanee F, Beibam LS, Bernard B. Conrauinones A and B, two new isoflavones from stem bark of Millettia conraui. J Nat Prod 1998; 61 (3): 380-383.
20. Jean W, Tanee FZ, François T, Francine L, Michel K. Erysenegalenseins B and C, Two new prenylated isoflavanones from Erythrina senegalensis. J Nat Prod 1995; 58 (1):105-108.
21. Tomoyuki Yasunaga, Takenori Kimura, Ryo Naito, Toru Kontani, Fumikazu Wanibuchi, Hiroshi Yamashita, et al. Synthesis and pharmacological characterization of novel 6-Fluorochroman derivatives as potential 5-HT1A receptor antagonists. J Med Chem 1998; 41 (15): 2765-2778.
22. Sukbok Chang and Robert H. Grubbs. A highly efficient and practical synthesis of Chromene derivatives using ring-closing olefin metathesis. J Org Chem 1998; 63:864-866.
23. Ramin GV, Zahra TS, Rahman KN. One-pot synthesis of 4H-Chromene and Dihydropyrano[3,2-c]chromene derivatives in hydroalcoholic media. J Braz Chem Soc 2011; 22:905-909.
24. Shinobu Kudoh, Hideki Okada, Kazuo Nakahira, Hiroshi Nakamura. Simultaneous Determination of Antihypertensive Agent Cromakalim and Its Major Metabolites in Human Urine by High Performance Liquid Chromatography. Analyt Sci 1990; 6:53-56.
25. Anthony LA, Vi Pham, Siying Ye, Leelee Ng, Rebecca AL, Philip ET, et al. Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase. Mol Pharmacol 2010; 78:600-607.
26. Bita B, Majid MH, Hossein AO. A Novel and efficient catalyst to one-pot synthesis of 2-Amino-4H-chromenes by p-toluenesulfonic acid. J Kor Chem Soc 2009; 53:631-633.
27. Juliana PMG, Cássia RPC, Eliana AV, José-Manuel M, Mariana FF, Nicolás Olea, et al. Antitumoral, mutagenic and (anti)estrogenic activities of tingenone and pristimerin. Rev Bras Farmacogn 2011; 21(6): 963-971.
28. Vosooghi M, Rajabalian S, Sorkhi M, Badinloo M, Nakhjiri M, Negahbani AS, et al. Synthesis and cytotoxic activity of some 2-amino-4-aryl-3-cyano-7-(dimethylamino)-4H-chromenes. Res Pharm Sci 2010; 5(1): 9-14.
29. Li J, Wang XL, Fang YC, Wang CY. Tephrosin-induced autophagic cell death in A549 non-small cell lung cancer cells. J Asian Nat Prod Res 2010;12(11):992-1000.
30. Heny E, Indwiani A, Mustofa. Anticancer activity of calanone on Hela cell line. Indo J Chem 2010; 10(2): 240-244.
31. Ponco I, Mochammad C, Muhammad H, Iqmal T, Eva Vaulina YD, Harjono, et al. Novel anti-leukemia calanone compounds by quantitative structure-activity relationship AM1 semiempirical method. WASET 2010; 41:747-752.
32. Koch M. From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents. Bull Acad Natl Med. 2007;191(1):83-91.
33. Nishino H, Okuyama T, Takata M, Shibata S, Tokuda H, Takayasu J, et al. Studies on the anti-tumor-promoting activity of naturally occurring substances. IV. Pd-II [(+)anomalin, (+)praeruptorin B], a seselin-type coumarin, inhibits the promotion of skin tumor formation by 12-O-tetradecanoylphorbol-13-acetate in 7,12-dimethylbenz[a]anthracene-initiated mice. Carcinogenesis 1990;11(9):1557-61.
34. Shailaja K, Henriette G, Karen M, et al. Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity. Mol Cancer Ther 2004; 3:1365-1374.
35. Doshi JM, Tian D, Xing C. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylat e (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. J Med Chem. 2006; 49(26):7731-9.
36. Usama WH, Mohamed AO, Abd EG, Abu EG. Anticancer activity of some new synthesized tetrahydroquinoline and tetrahydrochromene carbonitrile derivatives. Am J Applied Sci 2011;8 (10): 945-952.
37. Kemnitzer W, Jiang S, Zhang H, Kasibhatla S, Crogan-Grundy C, Blais C, et al. Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based high-throughput screening assay. Bioorg Med Chem Lett 2008;18(20):5571-5.
38. William Kemnitzer, Shailaja Kasibhatla, Songchun Jiang, Hong Zhang, Jianghong Zhao, Shaojuan Jia, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7-and 5-, 6-, 8-positions Bioorg Med Chem Lett 2005; 15(21): 4745-4751.
39. Indulatha VN, Gopal N, Jayakar B. Anti-inflammatory activity of newly synthesised N-[4'-Oxo-2'-(substituted aryl/heteryl)-thiazolidin-3'-yl]-3-carboxamido-2H-chromen-2-one derivatives. Int J ChemTech Res Vol.3, No.4, pp 1930-1937, Oct-Dec 2011.
40. Afshin Z Sara A. Selective COX-2 inhibitors: A review of their structure-activity relationships. Iran J Pharm Res 2011; 10(4):655-683.
41. http://www.inventi.in/Article/pmm/26/11.aspx
42. Kwangwoo C, Song-Kyu P, Hwan MK, Yongseok C, Myung-Hwa K, Chun-Ho P, et al. Chromen-based TNF-a converting enzyme (TACE) inhibitors: Design, synthesis, and biological evaluation. Bioorg Med Chem 2008; 16: 530-535.
43. Turner CE, Elsohly MA. Biological activity of cannabichromene, its homologs and isomers. J Clin Pharmacol 1981; 21:283-291.